IMMUNOGLOBULIN A NEPHROPATHY (IGAN)

Clinical trials for IMMUNOGLOBULIN A NEPHROPATHY (IGAN) explained in plain language.

Never miss a new study

Get alerted when new IMMUNOGLOBULIN A NEPHROPATHY (IGAN) trials appear

Sign up with your email to follow new studies for IMMUNOGLOBULIN A NEPHROPATHY (IGAN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 2

New drug trial aims to halt silent kidney killer

Disease control Recruiting now

This study is testing an investigational drug called felzartamab to see if it can protect the kidneys of adults with IgA nephropathy, a disease that causes protein to leak into the urine and can lead to kidney failure. Researchers will compare felzartamab to a placebo (inactive s…

Matched conditions: IMMUNOGLOBULIN A NEPHROPATHY (IGAN)

Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control

Last updated Mar 17, 2026 13:08 UTC

IMMUNOGLOBULIN A NEPHROPATHY (IGAN)

Get alerted when new IMMUNOGLOBULIN A NEPHROPATHY (IGAN) trials appear

New drug trial aims to halt silent kidney killer